Sorrento Therapeutics

Search
  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • COVID-19
    • Immunotherapy
    • Pain
    • Lymphatic Drug Delivery
    • Product Candidates
    • Clinical Trials
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC Filings
    • Stock
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Careers
  • Contact
en English▼
X
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sudanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu

10-KA

10KA-filed-on-6-27-17

srne-20170331.xml

srne-20170331

srne-20170331.xsd

srne-20170331

srne-20170331_pre.xml

srne-20170331_pre

srne-20170331_lab.xml

srne-20170331_lab

srne-20170331_def.xml

srne-20170331_def

srne-20170331_cal.xml

srne-20170331_cal

10-K

SORRENTO_THERAPEUTICS_IN_10KA_20170428

srne-20161231.xml

srne-20161231.xml

srne-20161231.xsd

srne-20161231.xsd

© 2023 Sorrento Therapeutics, Inc. All Rights Reserved. Terms of Use | Forward Looking Statements | Privacy Policy | Cookie Policy | Notices
logo
  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • COVID-19
    • Immunotherapy
    • Pain
    • Lymphatic Drug Delivery
    • Product Candidates
    • Clinical Trials
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC Filings
    • Stock
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Careers
  • Contact